{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:20:12Z","timestamp":1791256812477,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570786"],"award-info":[{"award-number":["81570786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.semarthrit.2021.12.011","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T11:16:33Z","timestamp":1640862993000},"page":"151943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Association between serum amyloid A and rheumatoid arthritis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"52","author":[{"given":"Jielin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.12.011_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-020-0168-y","article-title":"Rheumatoid arthritis primer - behind the scenes","volume":"6","author":"Smolen","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0002","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.mayocp.2019.01.002","article-title":"Trends in prevalence of functional disability in rheumatoid arthritis compared with the general population","volume":"94","author":"Myasoedova","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0003","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.41571","article-title":"Prevalence, deaths, and disability-adjusted life years due to musculoskeletal disorders for 195 countries and territories 1990-2017","volume":"73","author":"Safiri","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0004","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.41517","article-title":"Obesity-related traits and the development of rheumatoid arthritis: evidence from genetic data","volume":"73","author":"Tang","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12842","article-title":"Lung inflammation in the pathogenesis of rheumatoid arthritis","volume":"294","author":"Demoruelle","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0006","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0007","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/ard.2009.125476","article-title":"Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0008","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/acr.22458","article-title":"Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years: relation to disease activity, joint damage, and comorbidity","volume":"67","author":"Kapetanovic","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00018-008-8321-x","article-title":"Serum amyloid A: an acute-phase protein involved in tumour pathogenesis","volume":"66","author":"Malle","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00011-010-0163-y","article-title":"Association between serum amyloid A and obesity: a meta-analysis and systematic review","volume":"59","author":"Zhao","year":"2010","journal-title":"Inflamm Res"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00011-020-01325-1","article-title":"Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies","volume":"69","author":"Zhou","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0012","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/postgradmedj-2018-136004","article-title":"Association between serum amyloid A levels and cancers: a systematic review and meta-analysis","volume":"94","author":"Zhou","year":"2018","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.631299","article-title":"Serum amyloid A in inflammatory rheumatic diseases: a compendious review of a renowned biomarker","volume":"11","author":"Sori\u0107 Hosman","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0014","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1194\/jlr.M900089-JLR200","article-title":"Serum amyloid A3 does not contribute to circulating SAA levels","volume":"50","author":"Chiba","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0015","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults","volume":"23","author":"De Buck","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0016","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1002\/pmic.201400382","article-title":"Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays","volume":"15","author":"Kim","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.talanta.2019.06.044","article-title":"Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis","volume":"204","author":"Nys","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0018","first-page":"S63","article-title":"Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist","volume":"32","author":"Pastore","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0019","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2016.03.004","article-title":"Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist","volume":"46","author":"Charles-Schoeman","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/929246","article-title":"Sexual Dimorphisms of adrenal steroids, sex hormones, and immunological biomarkers and possible risk factors for developing rheumatoid arthritis","volume":"2015","author":"Masi","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0024","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/rheumatology\/ker011","article-title":"Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis","volume":"50","author":"Rooney","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0025","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3892\/mmr.2014.2804","article-title":"Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis","volume":"11","author":"Shen","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0026","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.atherosclerosis.2014.09.034","article-title":"Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation","volume":"237","author":"G\u00f3mez Rosso","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0027","article-title":"Clinical significance of serum amyloid protein A in rheumatoid arthritis","volume":"26","author":"Xiang","year":"2016","journal-title":"Chin J Health Lab Tec"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0028","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1507\/endocrj.43.241","article-title":"Differential changes of corticotropin releasing hormone (CRH) concentrations in plasma and synovial fluids of patients with rheumatoid arthritis (RA)","volume":"43","author":"Nishioka","year":"1996","journal-title":"Endocr J"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0029","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/molecules22050805","article-title":"Identification and validation of SAA4 as a rheumatoid arthritis prescreening marker by liquid chromatography tandem-mass spectrometry","volume":"22","author":"Seok","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.577523","article-title":"Detection of citrullinated fibrin in plasma clots of rheumatoid arthritis patients and its relation to altered structural clot properties, disease-related inflammation and prothrombotic tendency","volume":"11","author":"Bezuidenhout","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106380","article-title":"Analysis of serum rheumatoid factors in patients with rheumatoid arthritis in Han, Tibetan and Hui nationalities in Qinghai","volume":"83","author":"Yuan","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0032","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.41.3.268","article-title":"Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus","volume":"41","author":"Maury","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0033","first-page":"108","article-title":"Serum amyloid A: an indication of inflammation in rheumatoid arthritis","volume":"6","author":"Liu","year":"2002","journal-title":"Chin J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0034","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13075-017-1334-9","article-title":"Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis","volume":"19","author":"Yoo","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/ard.39.3.228","article-title":"Serum amyloid protein levels in south American children with rheumatoid arthritis: a co-operative study","volume":"39","author":"Scheinberg","year":"1980","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0036","first-page":"46","article-title":"Genic polymorphism of serum amyloid A1 and amyloidosis of rheumatoid arthritis","volume":"26","author":"Yu","year":"2009","journal-title":"J Xinxiang Med Coll"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0037","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2169\/internalmedicine.42.800","article-title":"Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis","volume":"42","author":"Ishii","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0038","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/bmj.284.6316.617","article-title":"Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis","volume":"284","author":"Wegelius","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/CCLM.2006.012","article-title":"Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA","volume":"44","author":"Xu","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/183653","article-title":"Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis","volume":"2013","author":"Ally","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/793628","article-title":"Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis","volume":"2014","author":"Targo\u0144ska-St\u0119pniak","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0042","first-page":"58","article-title":"Serum amyloid A in the assessment of early inflammatory arthritis","volume":"27","author":"Cunnane","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0043","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-016-1009-y","article-title":"Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker","volume":"18","author":"Hwang","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0044","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/art.33455","article-title":"Acute-phase serum amyloid A regulates tumor necrosis factor \u03b1 and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy","volume":"64","author":"Connolly","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0045","doi-asserted-by":"crossref","first-page":"e13394","DOI":"10.1097\/MD.0000000000013394","article-title":"Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset Still's disease","volume":"97","author":"Yashiro","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0046","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/13506129809007299","article-title":"SAA1 alleles as risk factors in reactive systemic AA amyloidosis","volume":"5","author":"Booth","year":"1998","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0047","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/hmg\/4.6.1083","article-title":"A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis","volume":"4","author":"Baba","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0048","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s004399900150","article-title":"Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis","volume":"105","author":"Moriguchi","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0049","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13506120308995250","article-title":"An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians","volume":"10","author":"Yamada","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/ard.60.2.124","article-title":"Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis","volume":"60","author":"Yamada","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0051","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/13506129809003847","article-title":"The frequency of serum amyloid A2 alleles in the Japanese population","volume":"5","author":"Yamada","year":"1998","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0052","first-page":"3","article-title":"Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis","volume":"39","author":"Okuda","year":"1999","journal-title":"Ryumachi"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129.2014.980942","article-title":"Risk factors for AA amyloidosis in Germany","volume":"22","author":"Blank","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0054","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/kei112","article-title":"Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis","volume":"45","author":"Nakamura","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0055","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.lfs.2003.08.025","article-title":"Interleukin-18 induces serum amyloid A (SAA) protein production from rheumatoid synovial fibroblasts","volume":"74","author":"Tanaka","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0056","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/art.20301","article-title":"Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis","volume":"50","author":"O'Hara","year":"2004","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0057","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.21518","article-title":"Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NFkappaB-dependent signal transduction pathway","volume":"54","author":"Mullan","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0058","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.4049\/jimmunol.178.3.1852","article-title":"Serum amyloid A induces monocyte tissue factor","volume":"178","author":"Cai","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0059","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2006.063834","volume":"66","author":"Matsui","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12016-007-8018-1","article-title":"Does the presence of anti-CCP autoantibodies and their serum levels influence the severity and activity in rheumatoid arthritis patients?","volume":"34","author":"Papadopoulos","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0061","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/ard.2007.073825","article-title":"Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors","volume":"67","author":"J\u00f8rgensen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0062","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0063","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.058529","article-title":"Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis","volume":"65","author":"Koenders","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0064","first-page":"752","article-title":"Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products","volume":"35","author":"Okamoto","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/acr.23427","article-title":"Low hemoglobin and radiographic damage progression in early rheumatoid arthritis: secondary analysis from a phase III trial","volume":"70","author":"M\u00f6ller","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2021.12.011_bib0066","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/kei112","article-title":"Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis","volume":"45","author":"Nakamura","year":"2006","journal-title":"Rheumatology (Oxford)"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221002249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221002249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:08:47Z","timestamp":1758733727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221002249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":66,"alternative-id":["S0049017221002249"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.12.011","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between serum amyloid A and rheumatoid arthritis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151943"}}